Make your money go further for just 25p per day

PREMIUM

Why India is the new China – but better

World map with magnifying glass zoomed in on India

India’s economy is primed for growth and its stock markets are set to benefit. In this overview, we set to prove why emerging market investors should look here instead of China and select three funds which could help you reap the rewards.


Economic growth at 6.2% is hardly a figure to be scorned, but the great China growth engine is certainly not what it used to be. Gone are the years of double-digit expansion, driven by a manufacturing economy that was happy in its role as the factory of the world. Today, China must be content with the gradual deceleration that was always inevitable as its economy matured.

Not that the latest phase of the Chinese growth story is necessarily a bad thing. China is attempting to turn from a manufacturing giant to a service led economy – a shift that could bring better equality, healthcare, education and job opportunities. There are therefore big sections of the Chinese markets which still look exciting for investors. Early stage tech and science companies, for example, which have now found a home on the new Star Market, China’s answer to Nasdaq. The appetite for innovation is certainly high – shares in companies listed on Star rocketed…

Continue reading this article…

Enjoy FREE access to the top news and insights from the investment world and our introductory finance guides.
  • Informative guides
  • Unique podcasts
  • Financial news and political insight
Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • In depth coverage of many of the world’s great companies
  • Breaking news on potential upcoming disasters
  • Unique insights from our top research team

Have your say

Log in or register to view or add comments.

For access to the top news and insights from the investment world

REGISTER FREE TODAY

Become a Champion Investor for as little as £3.20 per report or get a year's worth of money-making analysis for just £90.

SUBSCRIBE NOW

More Investors Clinic

Battle of the booze: how to benefit from a battered market

14/08/2019 · C&C · Molson Coors

Do non-executive directors really add value to smaller quoted companies?

Taylor Wimpey vs Lennar: is there more value in a US housebuilder?

08/08/2019 · Lennar · Taylor Wimpey